(Q46006190)

English

Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

0 references

1 reference

based on heuristic

inferred from title

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

9

object named as

Masaki Mori

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

10

object named as

Yuichiro Doki

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Shuji Takiguchi

5

object named as

Shuji Takiguchi

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

1

object named as

Hiroshi Miyata

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

2

object named as

Akiko Yoshioka

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Toshiro Nishida

7

object named as

Toshiro Nishida

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Yoichiro Nushijima

4

object named as

Yoichiro Nushijima

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

8

object named as

Masayuki Mano

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

author name string

Makoto Yamasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Yoshiyuki Fujiwara

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

language of work or name

0 references

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

115

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

14

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

3324-3334

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

Surgical therapy of oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Multimodality therapy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of tumor "budding" in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24390

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24390

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19452547

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46006190&oldid=1747009054"